Product Information

VILAZODONE HCL 40 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.7989 per EA under NDC 69097098202. Its NADAC has been published 163 times since Oct 4, 2023.

FDA first approved this application on Apr 7, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VILAZODONE HCL 40 MG TABLET

Vilazodone hydrochloride
$0.7989per EA

Strength

40 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097098202

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

VILAZODONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208200

FDA Approved

4/7/2021

TE Code

AB

On Market Since

1/23/2023

Price Statistics

The NADAC for VILAZODONE HCL 40 MG TABLET has been published 163 times since Oct 4, 2023, and over the history we have for it it has declined 46.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7989 per EA
All-time high$1.6346 (Dec 13, 2023)
All-time low$0.7989 (Oct 21, 2026)
52-week high$1.2319
52-week low$0.7989
Median price$1.0778
Average price$1.1307
Largest weekly change-29.2% (Jul 17, 2024)
Weeks tracked163
Tracking sinceOct 4, 2023

Price History

1W

0.0%

1M

-4.9%

3M

-20.7%

6M

-33.0%

1Y

-30.2%

3Y

-46.9%

5Y

N/A

All

-46.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VILAZODONE HCL 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VILAZODONE HCL 40 MG TABLET, manufactured by Cipla USA Inc., is $0.7989 per EA (NDC 69097098202), effective Nov 11, 2026.

How has the price of VILAZODONE HCL 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for VILAZODONE HCL 40 MG TABLET has declined 46.6%. It has been tracked across 163 weekly CMS publications since Oct 4, 2023.

What are the highest and lowest recorded NADAC prices for VILAZODONE HCL 40 MG TABLET?

Since Oct 4, 2023, the NADAC for VILAZODONE HCL 40 MG TABLET has ranged from a low of $0.7989 (Oct 21, 2026) to a high of $1.6346 (Dec 13, 2023), with a median of $1.0778 per EA.

Are there cheaper alternatives to VILAZODONE HCL 40 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VILAZODONE HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures VILAZODONE HCL 40 MG TABLET?

VILAZODONE HCL 40 MG TABLET (NDC 69097098202) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.